Reviva Pharmaceuticals shares are trading lower after Maxim Group downgraded the stock from Buy to Hold.
Portfolio Pulse from Benzinga Newsdesk
Reviva Pharmaceuticals shares are trading lower after Maxim Group downgraded the stock from Buy to Hold.
August 16, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Reviva Pharmaceuticals shares are trading lower following a downgrade by Maxim Group from Buy to Hold.
The downgrade from Buy to Hold by Maxim Group is likely to negatively impact investor sentiment and lead to a short-term decline in RVPH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100